The power of the protocol

被引：26

作者：

Lassere, M ^{[1
]}

Johnson, K

机构：

[1] St George Hosp, Dept Rheumatol, Kogarah, NSW 2217, Australia

[2] M TAG, Chatswood, NSW, Australia

来源：

LANCET | 2002年 / 360卷 / 9346期

关键词：

D O I：

10.1016/S0140-6736(02)11652-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1620 / 1622

页数：3

共 13 条

[1] The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].

Altman, DG ;

Schulz, KF ;

Moher, D ;

Egger, M ;

Davidoff, F ;

Elbourne, D ;

Gotzsche, PC ;

Lang, T .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694

[2]

*ARTHR ADV COMM, 2001, M ARTHR ADV COMM

[3] Seminal pharmaceutical trials: maintaining masking in analysis [J].

Boers, M .

LANCET, 2002, 360 (9327) :100-101

[4] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[5]

Geis GS, 2002, BRIT MED J, V325, P161

[6] The clinical trial: Deceitful, disputable, unbelievable, unhelpful, and shameful - What next? [J].

Horton, R .

CONTROLLED CLINICAL TRIALS, 2001, 22 (06) :593-604

[7]

ICH Harmonised Tripartite Guidelines Impurities in New Drug Substances Q3A(R1), 2002, INT C HARM TECHN REQ

[8] Are selective COX 2 hihibitors superior to traditional non steroidal anti-inflammatory drugs?: Adequate analysis of the CLASS trial indicates that this may not be the case [J].

Jüni, P ;

Rutjes, AWS ;

Dieppe, PA .

BRITISH MEDICAL JOURNAL, 2002, 324 (7349) :1287-1288

[9]

JUNI P, 2002, BRIT MED J, V325, P161

[10]

JUNI P, 2002, BMJ 0709

← 1 2 →